Johan M. Kros

33.7k citations

274 papers · 19.2k indexed · 5 hit papers · h-index 66

Impact in

Genetics top 0.01%
- Glioma Diagnosis and Treatment
Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation

Papers in

Genetics 140
- Glioma Diagnosis and Treatment 138
Cancer Research 58
- Cancer, Hypoxia, and Metabolism 25

Co-authors: Martin J. van den Bent Thierry Gorlia Michael Weller Roger Stupp Jacoline E. C. Bromberg Monika E. Hegi Johannes A. Hainfellner R.O. Mirimanoff
Journals: Neuro-Oncology (26 papers)Journal of Clinical Oncology (20 papers)Journal of Neuropathology & Experimental Neurology (18 papers)Acta Neuropathologica (11 papers)Cancer (11 papers)
Partner nations: Netherlands United States France

In The Last Decade

Johan M. Kros

265 papers receiving 18.9k citations

Hit Papers

5 papers align trajectories log scale

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 2020 · 310 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Acta Neuropathologica
2016 Neuro-Oncology
2012 Journal of Clinical Oncology
2009 Cancer Research
2005 New England Journal of Medicine

Peers

Countries citing papers authored by Johan M. Kros

Since Specialization

Citations

This map shows the geographic impact of Johan M. Kros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan M. Kros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan M. Kros more than expected).

Fields of papers citing papers by Johan M. Kros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan M. Kros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan M. Kros. The network helps show where Johan M. Kros may publish in the future.

Co-authors

The 25 scholars most cited alongside Johan M. Kros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan M. Kros Line = papers co-authored together Johan M. Kros links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	T cell induced expression of Coronin-1A facilitates blood-brain barrier transmigration of breast cancer cells Scientific Reports ·Johan M. Kros, Lona Zeneyedpour, Rute M. S. M. Pedrosa, Zineb Belcaid, Willem A. Dik, Theo M. Luider, Dana A. M. Mustafa	2024	0
2	MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology Cancers ·Fatemeh Arzanforoosh, Maaike Van der Velden, Avery Berman, Sebastian R. van der Voort, Eelke M. Bos, Joost W. Schouten, Arnaud J.P.E. Vincent, Johan M. Kros, Marion Smits, Esther A. H. Warnert	2023	6
3	Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors Journal of Clinical Oncology ·Andrew B. Lassman, Khê Hoang‐Xuan, Mei‐Yin C. Polley, Alba A. Brandes, J. Gregory Cairncross, Johan M. Kros, Lynn S. Ashby, Martin Taphoorn, Luís Souhami, Winand N.M. Dinjens, Nadia N. Laack, Mathilde C.M. Kouwenhoven, Karen Fink, Pim J. French, David R. Macdonald, Denis Lacombe, Minhee Won, Thierry Gorlia, Minesh P. Mehta, Martin J. van den Bent	2022	43
4	Differential Expression of BOC, SPOCK2, and GJD3 Is Associated with Brain Metastasis of ER-Negative Breast Cancers Cancers ·Rute M. S. M. Pedrosa, Leonoor V. Wismans, Renata Sinke, Marcel van der Weiden, Casper H.J. van Eijck, Johan M. Kros, Dana A. M. Mustafa	2021	12
5	Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases Clinical Cancer Research ·Lindsay Angus, Teoman Deger, Agnes Jager, John W.M. Martens, Vanja de Weerd, Irene van Heuvel, Martin J. van den Bent, Peter A.E. Sillevis Smitt, Johan M. Kros, Eric M. Bindels, Ellen Heitzer, Stefan Sleijfer, Joost L.M. Jongen, Saskia M. Wilting	2021	22
6	Identification of Blood–Brain Barrier-Associated Proteins in the Human Brain Journal of Proteome Research ·Marina Zajec, Johan M. Kros, Diana A. T. Dekker-Nijholt, Lennard J. M. Dekker, Christoph Stingl, Marcel van der Weiden, Thierry P. P. van den Bosch, Dana A. M. Mustafa, Theo M. Luider	2020	8
7	Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome Nature Neuroscience ·Rossella Avagliano Trezza, Monica Sonzogni, Stijn N. V. Bossuyt, F. Isabella Zampeta, A. Mattijs Punt, Marlene van den Berg, Diana C. Rotaru, Linda M. C. Koene, Shashini T. Munshi, Jeffrey Stedehouder, Johan M. Kros, Mark Williams, Helen Heussler, Femke M.S. de Vrij, Edwin Mientjes, Geeske M. van Woerden, Steven A. Kushner, Ben Distel, Ype Elgersma	2019	71
8	Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration Journal of Oncology ·Karin Huizer, Andrea Sacchetti, Wim A. Dik, Dana A. M. Mustafa, Johan M. Kros	2019	6
9	Defining EGFR amplification status for clinical trial inclusion Neuro-Oncology ·Pim J. French, Marica Eoli, Juan Manuel Sepúlveda-Sánchez, Iris de Heer, Johan M. Kros, Annemiek Walenkamp, Jean‐Sébastien Frenel, Enrico Franceschi, Paul M. Clément, Michael Weller, Peter Ansell, Jim Looman, Earle Bain, Marie Morfouace, Thierry Gorlia, Martin J. van den Bent	2019	28
10	CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions Angiogenesis ·Ihsan Chrifi, Laura Louzao-Martinez, Maarten M. Brandt, Chris Van Dijk, Petra E. Bürgisser, Changbin Zhu, Johan M. Kros, Marianne C. Verhaar, Dirk J. Duncker, Caroline Cheng	2018	59
11	MGMT -STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951 Clinical Cancer Research ·Martin J. van den Bent, Lale Erdem‐Eraslan, Ahmed Idbaïh, Johan de Rooi, Paul H.C. Eilers, Wim G.M. Spliet, Wilfred F.A. den Dunnen, Cees Tijssen, Pieter Wesseling, Peter A.E. Sillevis Smitt, Johan M. Kros, Thierry Gorlia, Pim J. French	2013	95
12	Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 Journal of Clinical Oncology ·Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros, Mathilde C.M. Kouwenhoven, Jean‐Yves Delattre, Hans J.J.A. Bernsen, Marc Frénay, Cees Tijssen, Wolfgang Grisold, László Sípos, Roelien H. Enting, Pim J. French, Winand N.M. Dinjens, Charles J. Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang‐Xuan Hit paper breakdown →	2012	804
13	LONG-TERM FOLLOW-UP OF EORTC 26951, A RANDOMIZED TRIAL ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS. A REPORT OF THE EORTC BTG. Data Archiving and Networked Services (DANS) ·Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros, Mathilde C.M. Kouwenhoven, Jean‐Yves Delattre, Hans J.J.B. Bernsen, Marc Frénay, Cees Tijssen, Wolfgang Grisold, Laslo Sipos, Roelien H. Enting, Pim J. French, Winand N.M. Dinjens, Charles J. Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang‐Xuan	2012	0
14	A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951 Clinical Cancer Research ·Martin J. van den Bent, Lonneke A.M. Gravendeel, Thierry Gorlia, Johan M. Kros, Lariesa Lapre, Pieter Wesseling, Johannes L. Teepen, Ahmed Idbaïh, Marc Sanson, Peter A.E. Sillevis Smitt, Pim J. French	2011	83
15	HeNe Laser (633 nm)-Coupled Confocal Microscope Allows Simulating Magnetic Resonance Imaging/Computed Tomography Scan of the Brain and Eye: A Noninvasive Optical Approach Applicable to Small Laboratory Animals Zebrafish ·Ping‐Pin Zheng, Edwin Romme, Peter J. van der Spek, Clemens M.F. Dirven, Rob Willemsen, Johan M. Kros	2011	2
16	IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group Clinical Cancer Research ·Martin J. van den Bent, Hendrikus J. Dubbink, Yannick Marie, Alba A. Brandes, Martin Taphoorn, Pieter Wesseling, Marc Frénay, Cees Tijssen, Denis Lacombe, Ahmed Idbaïh, Ronald van Marion, Johan M. Kros, Winand N.M. Dinjens, Thierry Gorlia, Marc Sanson	2010	304
17	Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology Cancer Research ·Lonneke A.M. Gravendeel, Mathilde C.M. Kouwenhoven, Olivier Gevaert, Johan J. de Rooi, Andrew Stubbs, J. Elza Duijm, Anneleen Daemen, Fonnet E. Bleeker, Linda B.C. Bralten, Nanne K. Kloosterhof, Bart De Moor, Paul H.C. Eilers, Peter J. van der Spek, Johan M. Kros, Peter A.E. Sillevis Smitt, Martin J. van den Bent, Pim J. French Hit paper breakdown →	2009	512
18	Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays Cancer Research ·Pim J. French, Justine Peeters, Sebastiaan Horsman, Elza Duijm, Ivar Siccama, Martin J. van den Bent, Theo M. Luider, Johan M. Kros, Peter J. van der Spek, Peter A. Sillevis Smitt	2007	70
19	Tussen schijn en werkelijkheid Data Archiving and Networked Services (DANS) ·Johan M. Kros	2006	1
20	Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas Cancer Research ·Pim J. French, Sigrid Swagemakers, Jord H.A. Nagel, Mathilde C.M. Kouwenhoven, Eric Brouwer, Peter J. van der Spek, Theo M. Luider, Johan M. Kros, Martin J. van den Bent, Peter A. Sillevis Smitt	2005	99

About Johan M. Kros

Johan M. Kros is a scholar working on Genetics, Cancer Research, Neurology, Neurology and Pulmonary and Respiratory Medicine, having authored 274 papers that have together received 19.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (138 papers), Brain Metastases and Treatment (50 papers), Meningioma and schwannoma management (26 papers), Cancer, Hypoxia, and Metabolism (25 papers), Radiomics and Machine Learning in Medical Imaging (20 papers), Neuroblastoma Research and Treatments (14 papers), Histone Deacetylase Inhibitors Research (13 papers) and Epigenetics and DNA Methylation (13 papers). The work is most often cited by research in Genetics (11.6k citations), Cancer Research (4.7k citations), Neurology (2.9k citations), Pulmonary and Respiratory Medicine (4.6k citations) and Radiology, Nuclear Medicine and Imaging (2.5k citations). Johan M. Kros has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Martin J. van den Bent, Thierry Gorlia, Michael Weller, Roger Stupp, Jacoline E. C. Bromberg, Monika E. Hegi, Johannes A. Hainfellner, R.O. Mirimanoff, Peter Hau and Warren Mason. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuropathology & Experimental Neurology, Acta Neuropathologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact